A phase I study of docetaxel, capecitabine and oxaliplatin (DXO) in patients with advanced stomach cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Docetaxel; Oxaliplatin
- Indications Gastric cancer
- Focus Adverse reactions
- 18 Jan 2020 Biomarkers information updated
- 16 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2007 New trial record.